Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Renovacor Inc (NY: RCOR )

N/A UNCHANGED
Last Price Updated: 8:00 PM EST, Nov 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Renovacor Inc

Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress
From Renovacor, Inc.
Via Business Wire
Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference
From Renovacor, Inc.
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EVOP, STOR, RCKT, RCOR
Via ACCESSWIRE
RCOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Renovacor, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy
From Rocket Pharmaceuticals, Inc. and Renovacor, Inc.
Via Business Wire
Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update
From Renovacor, Inc.
Via Business Wire
Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy
From Renovacor, Inc.
Via Business Wire
Renovacor Announces Data from Pilot Pig Study Showing Successful Cardiac Transduction with REN-001 Delivered Via Low-Dose Retrograde Coronary Sinus Infusion Published in Journal of the American College of Cardiology: Basic to Translational Research
From Renovacor, Inc.
Via Business Wire
Renovacor Reports First Quarter 2022 Financial Results and Provides Corporate Update
From Renovacor, Inc.
Via Business Wire
Renovacor Announces the Appointment of Fred Driscoll as Chief Financial Officer
From Renovacor, Inc.
Via Business Wire
Renovacor Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
From Renovacor, Inc.
Via Business Wire
Renovacor to Participate in a Panel Presentation at the 11th Annual LifeSci Partners Corporate Access Event
From Renovacor, Inc.
Via Business Wire
Renovacor Announces Third Quarter 2021 Financial Results and Provides Corporate Update
From Renovacor, Inc.
Via Business Wire
Renovacor Announces the Appointment of Kumar Dhanasekharan, Ph.D., as Senior Vice President of Technical Operations
From Renovacor, Inc.
Via Business Wire
Renovacor to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
From Renovacor, Inc.
Via Business Wire
Renovacor Announces the Appointment of Jordan Shin, M.D., Ph.D., as Senior Vice President of Clinical Development and Translational Science
From Renovacor, Inc.
Via Business Wire
Renovacor to Present at the 2021 Virtual Wells Fargo Healthcare Conference
From Renovacor, Inc.
Via Business Wire
Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange
From Renovacor, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.